These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19804412)
1. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412 [TBL] [Abstract][Full Text] [Related]
2. The pro-form of BMP-2 exhibits a delayed and reduced activity when compared to mature BMP-2. von Einem S; Erler S; Bigl K; Frerich B; Schwarz E Growth Factors; 2011 Apr; 29(2-3):63-71. PubMed ID: 21391795 [TBL] [Abstract][Full Text] [Related]
3. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Hartung A; Bitton-Worms K; Rechtman MM; Wenzel V; Boergermann JH; Hassel S; Henis YI; Knaus P Mol Cell Biol; 2006 Oct; 26(20):7791-805. PubMed ID: 16923969 [TBL] [Abstract][Full Text] [Related]
4. Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium. Kémoun P; Laurencin-Dalicieux S; Rue J; Vaysse F; Roméas A; Arzate H; Conte-Auriol F; Farges JC; Salles JP; Brunel G Tissue Cell; 2007 Aug; 39(4):257-66. PubMed ID: 17662325 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Ye L; Kynaston H; Jiang WG Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975 [TBL] [Abstract][Full Text] [Related]
6. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849 [TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults. Abir R; Ben-Haroush A; Melamed N; Felz C; Krissi H; Fisch B Fertil Steril; 2008 May; 89(5 Suppl):1430-40. PubMed ID: 17624341 [TBL] [Abstract][Full Text] [Related]
8. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor. Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937 [TBL] [Abstract][Full Text] [Related]
9. PLAP-1/asporin inhibits activation of BMP receptor via its leucine-rich repeat motif. Tomoeda M; Yamada S; Shirai H; Ozawa Y; Yanagita M; Murakami S Biochem Biophys Res Commun; 2008 Jun; 371(2):191-6. PubMed ID: 18407830 [TBL] [Abstract][Full Text] [Related]
10. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2. Singhatanadgit W; Mordan N; Salih V; Olsen I Int J Biochem Cell Biol; 2008; 40(12):2854-64. PubMed ID: 18619554 [TBL] [Abstract][Full Text] [Related]
11. Expression patterns of BMPRs in the developing mouse molar. Nadiri A; Kuchler-Bopp S; Perrin-Schmitt F; Lesot H Cell Tissue Res; 2006 Apr; 324(1):33-40. PubMed ID: 16432712 [TBL] [Abstract][Full Text] [Related]
12. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Shi W; Chang C; Nie S; Xie S; Wan M; Cao X J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069 [TBL] [Abstract][Full Text] [Related]
13. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905 [TBL] [Abstract][Full Text] [Related]
14. Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro. Kémoun P; Laurencin-Dalicieux S; Rue J; Farges JC; Gennero I; Conte-Auriol F; Briand-Mesange F; Gadelorge M; Arzate H; Narayanan AS; Brunel G; Salles JP Cell Tissue Res; 2007 Aug; 329(2):283-94. PubMed ID: 17443352 [TBL] [Abstract][Full Text] [Related]
15. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. Nohe A; Keating E; Underhill TM; Knaus P; Petersen NO J Cell Sci; 2003 Aug; 116(Pt 16):3277-84. PubMed ID: 12829744 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro. Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Zhang JL; Qiu LY; Kotzsch A; Weidauer S; Patterson L; Hammerschmidt M; Sebald W; Mueller TD Dev Cell; 2008 May; 14(5):739-50. PubMed ID: 18477456 [TBL] [Abstract][Full Text] [Related]
18. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. Nickel J; Dreyer MK; Kirsch T; Sebald W J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668 [TBL] [Abstract][Full Text] [Related]
19. Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity. Sieber C; Plöger F; Schwappacher R; Bechtold R; Hanke M; Kawai S; Muraki Y; Katsuura M; Kimura M; Rechtman MM; Henis YI; Pohl J; Knaus P Biol Chem; 2006 Apr; 387(4):451-60. PubMed ID: 16606344 [TBL] [Abstract][Full Text] [Related]
20. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells. Singhatanadgit W; Salih V; Olsen I Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]